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Other names: RNASE6PL; RP11-514O12.3; 
bA514O12.3 
Location: 6q27 
Local order: Telomeric to RPS6KA2, centromeric to 
FGFR1OP. 
Note: This gene is the first human member of the 
Rh/T2/S-glycoprotein family of extracellular 
ribonucleases. It is a putative class II tumor suppressor 
gene potentially involved in the pathogenesis of several 
solid and haematologic human neoplasias such as 




This gene is split in 9 exons spanning approximatly 27  
kb of genomic DNA. The translation initiation codon is 
located to exon 1 and the stop codon to exon 9. Exons 
III and VI encode the two CAS motifs (Catalytic 
Active Sites) responsible for the ribonuclease activity 
of the RNASET2 protein. 
Transcription 
The RNASET2 gene is transcribed in the telomere-to-
centromere orientation to produce an ubiquitously 
expressed mRNA approximately 1,4 kb in length. EST 
clones representing splice variants of the same gene 
have been described. 
Pseudogene 
A processed pseudogene showing 85% identity with 
RNASET2 mRNA maps to chromosome 7p11.2. The 
























The full-length RNASET2 protein contains 256 
aminoacids and displays an apparent MW of 36 kDa in 
its secreted form. Two 31 and 27 kDa C-terminal 
proteolytic products have also been observed 
intracellularly in several human cancer cell lines and 
localize to the lysosome. 
Expression 
Expression of the RNASET2 protein has been detected 
in several human ovarian cancer cell lines and in some 
melanoma, prostate, pancreatic and breast carcinoma 
cell lines. 
Localisation 
The RNASET2 protein can be detected either 
intracellularly within lysosomes and secretory pathway, 
or extracellularly in a secreted form (in cell culture 
supernatants). 
Function 
Biochemical function: RNASET2 is an acid 
ribonuclease with optimal activity at pH 5 and 
preferential cleavage of poly-A and poly-U homo-
polyribonucleotides. 
Biological function: RNASET2 behaves as a class II 
tumor suppressor gene for ovarian cancer, since 
experimental overexpression of this gene in human 
ovarian cancer cell lines is associated with a significant 
decrease of their tumorigenic and metastasizing 
potential in vivo. Strikingly, the ribonuclease cataly ic 
activity is apparently dispensable for RNASET2 to play 
such antioncogenic role. Indeed, a double CAS mutant 
cDNA construct encoding an almost inactive 
RNASET2 protein is still able to suppress 
tumorigenicity and metastasis when overexpressed in 
the same ovarian cancer cell lines. Such results have 
been recently confirmed in a human melanoma cell 
line. 
Homology 
The primary sequenze of RNASET2 shows strong 




A common exon-9 missense C708T germline mutation 
has been described but no evidence for an association 
of this allele with human cancer was found. 
Somatic 
A few common polymorphisms in exons 1, 8 and 9 
have been described. 
Implicated in 
Human ovarian carcinoma 
Disease 
Loss of expression of RNASET2 occurs in a significant 
fraction of human ovarian cancer cell lines and prima y 
ovarian tumours. When overexpressed by gene transfer 
experiments in human ovarian cancer cell lines 
displaying a low level of endogenous mRNA, 
RNASET2 strongly suppresses the tumorigenic and 
metastatic potential of these cell lines in vivo. 
Cytogenetics 
The RNASET2 genes maps in a genomic region (6q27) 
which is frequently deleted or otherwise rearranged in a 
wide range of human neoplasias, including ovarian 
cancer. 
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